Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2025

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Presentation TCT 2025

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Presenter: Ulf Teichgräber

October 26, 2025

Presentation TCT 2025

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Presenter: Osamu Iida

October 26, 2025

Presentation TCT 2025

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

Presenter: Seung-Whan Lee

October 26, 2025

Presentation TCT 2025

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

Presenter: Yuki Sakamoto

October 26, 2025

Presentation TCT 2025

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

Presenter: YUKI SHIMA

October 26, 2025

Presentation TCT 2025

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

Presenter: Jonghu Shin

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Presenter: Ramon L. Varcoe

October 26, 2025

Advertisement

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content